Feburen 40 Tablet

About Feburen 40 Tablet

Feburen 40 is a 40 mg tablet containing febuxostat, a medicine used for the long-term management of high uric acid in people with gout. It is made by Renata PLC. and belongs to the group of drugs used in gout.

There are 18 brands of Febuxostat listed in Bangladesh. The lowest listed price is Fostat 80 mg Tablet at ৳ 10.00 per unit.

What is Feburen 40 Tablet?

Feburen 40 is a 40 mg tablet of febuxostat, a non-purine selective xanthine oxidase inhibitor. It works by blocking xanthine oxidase, the enzyme responsible for making uric acid, and so lowers the level of uric acid in the blood. It is used for the chronic management of hyperuricemia in patients with gout. It is not recommended for people who have high uric acid but no symptoms of gout. The tablet is made by Renata PLC. and is classed among drugs used in gout.

Uses of Feburen 40

Feburen 40 is used for the long-term management of hyperuricemia in people who have gout. It helps lower the uric acid level in the blood over time. It is not meant for treating asymptomatic hyperuricemia, that is, high uric acid without gout symptoms. Whether it suits a particular person is a decision for the doctor, who will consider the person's condition and history.

How to use Feburen 40

Feburen 40 is a tablet and is taken by mouth. The doctor decides the dose and how long it should be taken; do not change the dose or stop it on your own. It can be taken with or without food and without regard to antacid use. Tell your doctor about all other medicines you take, because some medicines should not be combined with it.

Side effects of Feburen 40

Side effects that may occur with Feburen 40 include liver function abnormalities, nausea, joint pain and rash. Gout flares can happen more often when treatment is started. A higher rate of cardiovascular thromboembolic events was seen with febuxostat than with allopurinol in clinical trials. Contact your doctor if you notice signs of a heart attack or stroke, yellowing of the skin or eyes, or any troublesome reaction.

Safety and precautions

Feburen 40 must not be used by people being treated with azathioprine, mercaptopurine or theophylline, because combining them can raise the levels of those drugs and cause severe toxicity. It is in pregnancy category C; there are no adequate and well-controlled studies in pregnant women, so it should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether it passes into human milk, so caution is needed in nursing women. Ask your doctor first if you are pregnant, breastfeeding, or have heart, liver or kidney problems.

Frequently asked questions

What is Feburen 40 used for and what kind of medicine is it?

It is used for the chronic management of high uric acid in people with gout. It is a xanthine oxidase inhibitor, a drug used in gout that lowers uric acid production. It is not recommended for high uric acid without gout symptoms.

What side effects should I watch for, and when should I call the doctor?

Watch for nausea, joint pain, rash and signs of liver problems. Gout flares may occur when treatment starts. Call your doctor if you notice signs of a heart attack or stroke, yellowing of the skin or eyes, or any reaction that worries you.

How should Feburen 40 be taken?

It is a tablet taken by mouth. Your doctor decides the dose and the length of the course, so follow their instructions and do not change the dose yourself. It can be taken with or without food. Tell your doctor about all other medicines you use.

Can Feburen 40 be taken with other medicines?

It must not be combined with azathioprine, mercaptopurine or theophylline, as this can cause severe toxicity. Before starting it, tell your doctor or pharmacist about every medicine you take, including those bought without a prescription, so they can check for interactions.

Indications

Febuxostat is indicated for the chronic management of hyperuricemia in patients with gout. Febuxostat is not recommended for the treatment of asymptomatic hyperuricemia.

Pharmacology

Febuxostat is a non-purine, selective xanthine oxidase (XO) inhibitor. It decreases serum uric acid level by inhibiting xanthine oxidase, which is responsible for uric acid production. Xanthine oxidase breaks down hypoxanthine to xanthine and thus to uric acid. Febuxostat is not expected to inhibit other enzymes involved in purine and pyrimidine synthesis and metabolism at therapeutic concentrations.

Dosage & Administration

Febuxostat is recommended at 40 mg or 80 mg once daily. The recommended starting dose of Febuxostat is 40 mg once daily. For patients who do not achieve a serum uric acid less than 6 mg /dL after 2 weeks with 40 mg, Febuxostat 80 mg is recommended. Febuxostat can be administered without regard to food or antacid use. No dose adjustment is necessary when administering Febuxostat to patients with mild to moderate renal or hepatic impairment.

Interaction

Concomitant administration of Febuxostat with azathioprine, mercaptopurine or theophylline could increase plasma concentrations of these drugs resulting in severe toxicity.

Contraindications

Febuxostat is contraindicated in patients being treated with azathioprine, mercaptopurine, or theophylline.

Side Effects

The most common adverse events associated with the use of Febuxostat may include liver function abnormalities, nausea, arthralgia, and rash.

Pregnancy & Lactation

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Febuxostat should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this drug is excreted in human milk. Caution should be exercised when Febuxostat is administered to a nursing woman.

Precautions & Warnings

Gout Flare: An increase in gout flares is frequently observed during initiation of anti-hyperuricemic agents, including Febuxostat. If a gout flare occurs during treatment, Febuxostat need not be discontinued. Prophylactic therapy (i.e., non-steroidal anti-inflammatory drug (NSAID) or colchicine upon initiation of treatment) may be beneficial for up to six months.

Cardiovascular Events: A higher rate of cardiovascular thromboembolic events was observed in patients treated with febuxostat than allopurinol in clinical trials. Monitor for signs and symptoms of MI and stroke.

Liver Enzyme Elevation: Transaminase elevations have been observed in febuxostat -treated patients. Monitor liver function tests periodically.

Overdose Effects

Febustat was studied in healthy subjects in doses up to 300 mg daily for seven days without evidence of dose-limiting toxicities.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Febuxostat

Other brands with the same generic name, cheapest first.

Barif Tablet

40 mg

Febuxostat

Square Pharmaceuticals Ltd.

৳ 12.03 per unit

Febus Tablet

40 mg

Febuxostat

Advanced Chemical Industries PLC

৳ 15.00 per unit

Barif Tablet

80 mg

Febuxostat

Square Pharmaceuticals Ltd.

৳ 22.06 per unit

Febus Tablet

80 mg

Febuxostat

Advanced Chemical Industries PLC

৳ 25.00 per unit

See all 18 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.